FASEB J.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nestler, J. E.
Right arrow Articles by Blackard, W. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nestler, J. E.
Right arrow Articles by Blackard, W. G.

The FASEB Journal, Vol 6, 3073-3075, Copyright © 1992 by The Federation of American Societies for Experimental Biology


REVIEWS

Dehydroepiandrosterone: the "missing link" between hyperinsulinemia and atherosclerosis?

JE Nestler, JN Clore and WG Blackard
Department of Medicine, Medical College of Virginia/Virginia Commonwealth University, Richmond 23298.

A well-established epidemiologic association exists between hyperinsulinemia and macrovascular disease. However, the mechanism or mechanisms by which hyperinsulinemia promotes atherogenesis is unknown. Recent evidence indicates that the adrenal steroid dehydroepiandrosterone (DHEA) exerts multiple antiatherogenic effects and also suggests that hyperinsulinemia may reduce serum DHEA and DHEA- sulfate levels by decreasing production and enhancing metabolic clearance. We advance the hypothesis that hyperinsulinemia promotes macrovascular disease in part by reducing serum DHEA and DHEA-sulfate levels and illustrate how this may be the case in two clinical conditions characterized by hyperinsulinemic insulin resistance: aging and obesity.


This article has been cited by other articles:


Home page
J EndocrinolHome page
R H Straub, L B Tanko, C Christiansen, P J Larsen, and D S Jessop
Higher physical activity is associated with increased androgens, low interleukin 6 and less aortic calcification in peripheral obese elderly women
J. Endocrinol., October 1, 2008; 199(1): 61 - 68.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
J. Nuver, A. J. Smit, B. H.R. Wolffenbuttel, W. J. Sluiter, H. J. Hoekstra, D. T. Sleijfer, and J. A. Gietema
The Metabolic Syndrome and Disturbances in Hormone Levels in Long-Term Survivors of Disseminated Testicular Cancer
J. Clin. Oncol., June 1, 2005; 23(16): 3718 - 3725.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
C. Molinari, A. Battaglia, E. Grossini, D. A. S. G. Mary, C. Vassanelli, and G. Vacca
The effect of dehydroepiandrosterone on regional blood flow in prepubertal anaesthetized pigs
J. Physiol., May 15, 2004; 557(1): 307 - 319.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
H. A. Feldman, C. B. Johannes, A. B. Araujo, B. A. Mohr, C. Longcope, and J. B. McKinlay
Low Dehydroepiandrosterone and Ischemic Heart Disease in Middle-aged Men: Prospective Results from the Massachusetts Male Aging Study
Am. J. Epidemiol., January 1, 2001; 153(1): 79 - 89.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
D. R. Pieper and C. A. Lobocki
Characterization of Serum Dehydroepiandrosterone Secretion in Golden Hamsters
Experimental Biology and Medicine, September 1, 2000; 224(4): 278 - 284.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
Y. Moriyama, H. Yasue, M. Yoshimura, Y. Mizuno, K. Nishiyama, R. Tsunoda, H. Kawano, K. Kugiyama, H. Ogawa, Y. Saito, et al.
The Plasma Levels of Dehydroepiandrosterone Sulfate Are Decreased in Patients with Chronic Heart Failure in Proportion to the Severity
J. Clin. Endocrinol. Metab., May 1, 2000; 85(5): 1834 - 1840.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. Kiechl, J. Willeit, E. Bonora, S. Schwarz, and Q. Xu
No Association Between Dehydroepiandrosterone Sulfate and Development of Atherosclerosis in a Prospective Population Study (Bruneck Study)
Arterioscler. Thromb. Vasc. Biol., April 1, 2000; 20(4): 1094 - 1100.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. McIntosh, D. Hausman, R. Martin, and G. Hausman
Dehydroepiandrosterone attenuates preadipocyte growth in primary cultures of stromal-vascular cells
Am J Physiol Endocrinol Metab, August 1, 1998; 275(2): E285 - E293.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
R. H. Straub, L. Konecna, S. Hrach, G. Rothe, M. Kreutz, J. Schölmerich, W. Falk, and B. Lang
Serum Dehydroepiandrosterone (DHEA) and DHEA Sulfate Are Negatively Correlated with Serum Interleukin-6 (IL-6), and DHEA Inhibits IL-6 Secretion from Mononuclear Cells in Man in Vitro: Possible Link between Endocrinosenescence and Immunosenescence
J. Clin. Endocrinol. Metab., June 1, 1998; 83(6): 2012 - 2017.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1992 by The Federation of American Societies for Experimental Biology.